The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
yttrium Y 90 ibritumomab tiuxetan
A radioimmunotherapeutic agent consisting of a murine monoclonal anti-CD20 antibody (ibritumomab) linked by the chelator tiuxetan to the radioisotope yttrium-90 (Y 90). Yttrium Y 90 ibritumomab tiuxetan binds to and specifically delivers beta radiation to CD20-expressing tumor cells, thereby minimizing the systemic effects of radiation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | 90Y ibritumomab tiuxetan Ibritumomab (In2B8/Y2B8 radiolabeling kit) ibritumomab tiuxetan IDEC-Y2B8 monoclonal antibody Y90 Zevalin Y90-labeled ibritumomab tiuxetan Yttrium-90 ibritumomab tiuxetan | |
| |||
| US brand name: | | Zevalin | |
| |||
| Code name: | | IDEC Y2B8 | |
| |||
